North America Neurotoxins Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Neurotoxins Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Neurotoxins Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Neurotoxins Market Regional Analysis

6.2 North America Neurotoxins Market Revenue 2021-2028 (US$ Million)

6.3 North America Neurotoxins Market Forecast Analysis

7. North America Neurotoxins Market Analysis – by Product Type

7.1 Botox

7.1.1 Overview
7.1.2 Botox: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

7.2 Dysport

7.2.1 Overview
7.2.2 Dysport: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

7.3 Xenomin

7.3.1 Overview
7.3.2 Xenomin: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

8. North America Neurotoxins Market Analysis – by Application

8.1 Therapeutic and Aesthetic

8.1.1 Overview
8.1.2 Therapeutic and Aesthetic: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9. North America Neurotoxins Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Hospitals: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9.2 Specialty Clinics

9.2.1 Overview
9.2.2 Specialty Clinics: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

9.3 Dermatology Clinics

9.3.1 Overview
9.3.2 Dermatology Clinics: North America Neurotoxins Market – Revenue and Forecast, 2021-2028 (US$ Million)

10. North America Neurotoxins Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Neurotoxins Market Breakdown, by Key Country, 2024 and 2028 (%)
10.2.1.1 North America Neurotoxins Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Neurotoxins Market Breakdown, by Product Type
10.2.1.1.2 US: North America Neurotoxins Market Breakdown, by Application
10.2.1.1.3 US: North America Neurotoxins Market Breakdown, by End User

10.2.1.2 Canada: North America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Neurotoxins Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Neurotoxins Market Breakdown, by Application
10.2.1.2.3 Canada: North America Neurotoxins Market Breakdown, by End User

10.2.1.3 Mexico : North America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Neurotoxins Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Neurotoxins Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Neurotoxins Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 AbbVie Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Hugel Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Ipsen SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Medytox Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Merz Pharma GmbH & Co KGaA

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Metabiologics

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Revance Therapeutics Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Neurotoxins Market

Analysis - by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)